✦ LIBER ✦

Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: A retrospective study

✍ Scribed by Lin, Kuan-Hsiang; Chen, Shih-Pin; Fuh, Jong-Ling; Wang, Yen-Feng; Wang, Shuu-Jiun

Book ID: 122316961
Publisher: Elsevier Science
Year: 2014
Tongue: Chinese
Weight: 183 KB
Volume: 77
Category: Article
ISSN: 1726-4901
DOI: 10.1016/j.jcma.2013.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Duration of Migraine Is a Predictor for

Duration of Migraine Is a Predictor for Response to Botulinum Toxin Type A

✍ Eric J. Eross; Jonathan P. Gladstone; Susan Lewis; Robert Rogers; David W. Dodic 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Treatment of Chronic Refractory Intracta

Treatment of Chronic Refractory Intractable Headache with Botulinum Toxin Type A: A Retrospective Study

✍ S. Raj Sundaraj; Paul Ponciano; Charlotte Johnstone; Faiz Noore; Maria Castro 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

The long-term efficacy and safety of bot

The long-term efficacy and safety of botulinum toxin in refractory chronic tension-type headache

✍ A. Kemal Erdemoglu; Ayhan Varlibas 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 408 KB

Predictors of Response to Botulinum Toxi

Predictors of Response to Botulinum Toxin Type A (BoNTA) in Chronic Daily Headache

✍ Ninan T. Mathew; Jayasree Kailasam; Lori Meadors 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Botulinum toxin type A in the treatment

Botulinum toxin type A in the treatment of chronic migraine and chronic tension-type headache

✍ Artemenko Ada; Orlova Olga 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Efficacy and safety of repeated doses of

Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia

✍ Stewart A. Factor; Eric S. Molho; Sharon Evans; Paul J. Feustel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Efficacy of botulinum toxin type B (BoNT B) for the treatment of type A‐resistant (AR) and non‐A‐resistant (NAR) cervical dystonia (CD) has been demonstrated in several single injection studies. There is little data available on long‐term therapy with repeated injection sessions and it